Historically, the medical community has focused principally on the arterial side of the circulation. However, pathologic venous congestion is increasingly being recognized an under-appreciated cause of harm in multiple patient populations, especially those with cardiac disease.1–3 Despite the importance of this clinical parameter, assessment of venous congestion remains challenging, as conventional physical exam findings depend on patient characteristics and provider experience. While ultrasound of the inferior vena cava (IVC) was thought to address these issues, studies have shown a lower-than expected clinical utility.4 Recognizing these barriers, clinicians often rely on right heart catheterization (RHC), the gold standard for assessment of venous congestion. Unfortunately, RHC is invasive, resource-intensive, and unavailable in many centers.5 These limitations demonstrate a need for a reliable, cost-effective, noninvasive means of measuring venous congestion.
To address this need, Beaubien-Souligny and colleagues developed the novel “Venous Excess Ultrasound (VExUS)” Score. The authors described a noninvasive 4-point exam combining IVC measurement with Doppler ultrasonography of the hepatic vein (HV), portal vein (PV), and renal veins (RV), and reported a positive likelihood ratio of 6.37 for cardiorenal acute kidney injury (AKI).2, 3 Since that time multiple reviews have been published on the use of VExUS, with a focus on its clinical utility for assessment of volume status.6–8 Subsequent validation studies found Sthat VExUS correlates with AKI and intracardiac pressures measured by RHC.9, 10 These preliminary findings have generated considerable interest in the technique, and multiple prospective trials evaluating its utility are currently underway.11, 12 However, despite its rapid adoption, much remains unknown about the VExUS score, including inter-rater reliability (IRR, consistency of interpretation by multiple different readers), and inter-user reproducibility (IUR, consistency of images acquired from one patient by multiple ultrasonographers), and whether or not a concurrent electrocardiogram (ECG) tracing is necessary for interpretation. Best practices and standardized protocols have not been established, and real-world implementation of VExUS varies widely. To address these gaps in the literature, we conducted a multi-center, multidisciplinary prospective observational study to assess IRR, IUR, and the necessity of a ECG tracing in the interpretation of VExUS images.